Trump to visit Fed on Thursday amid Powell feud, renovation probe
Investing.com -- Thermo Fisher Scientific Inc (NYSE:TMO) reported second-quarter earnings that topped expectations, with revenue also coming in ahead of forecasts.
The company reported adjusted EPS of $5.36, beating the analyst estimate of $5.23. Revenue rose 3% from a year earlier to $10.85 billion, above the $10.68 billion consensus.
Shares in the medical equipment maker were up 2.3% in premarket trading Wednesday as of 06:06 ET.
“Our exceptional team continues to execute at a high level, enabling customer success while navigating the macroenvironment," said Marc N. Casper, chairman, president, and CEO of Thermo Fisher Scientific.
Adjusted operating income reached $2.38 billion, slightly up from $2.35 billion in the same period last year.
Adjusted operating margin slipped to 21.9% from 22.3% a year ago.